Lonza Announces Results of the 2026 Annual General Meeting – All Motions Proposed by Board of Directors Approved

Lonza Announces Results of the 2026 Annual General Meeting – All Motions Proposed by Board of Directors Approved

A single swab is sufficient: Study paves the way for simplified tuberculosis diagnosis

A single swab is sufficient: Study paves the way for simplified tuberculosis diagnosis

Hella Bühler Prize Awarded to DKFZ Researcher Angelika Feldmann

Hella Bühler Prize Awarded to DKFZ Researcher Angelika Feldmann

New Nature Publication by Akribion Therapeutics GmbH: RNA-triggered cell killing with CRISPR–Cas12a2

New Nature Publication by Akribion Therapeutics GmbH: RNA-triggered cell killing with CRISPR–Cas12a2

VectorBuilder Secures European Patent for MiniVec™, a Plasmid Backbone Advancing Safety and Manufacturability in Genetic Medicine

VectorBuilder Secures European Patent for MiniVec™, a Plasmid Backbone Advancing Safety and Manufacturability in Genetic Medicine

Nobel-Potential Discovery from VectorBuilder Scientists Reveals Fundamental Mechanisms of Development

Nobel-Potential Discovery from VectorBuilder Scientists Reveals Fundamental Mechanisms of Development

AGC Biologics Wins 2026 Fierce Outsourcing Award for Leadership in Regulatory and Quality Compliance

AGC Biologics Wins 2026 Fierce Outsourcing Award for Leadership in Regulatory and Quality Compliance

Molecular research: When speed meets precision

Molecular research: When speed meets precision

Brain metastases from breast cancer: Immune cell patterns could improve treatment decisions

Brain metastases from breast cancer: Immune cell patterns could improve treatment decisions